The Dedham Group
- Kathryn Moses
KM
Kathryn Moses
Director Of Cell And Gene Therapy Strategy, Principal at The Dedham Group
Kathryn Moses is currently the Director of Cell and Gene Therapy Strategy at The Dedham Group. Prior to that, Kathryn held various positions at different companies such as General Electric and Dow Coating Materials. Kathryn has a Bachelor of Science in Chemical Engineering from the University of Michigan and a Minor in Business Administration from the Stephen M. Ross School of Business.
Timeline
Director Of Cell And Gene Therapy Strategy, Principal
January 1, 2024 - present
Associate Director of Cell & Gene Therapy Strategy, Engagement Manager
January, 2023
Senior Consultant
March, 2022
Consultant
August, 2021
Associate Consultant
January, 2021
Senior Analyst
December, 2019
Analyst
January, 2019
